アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

vetoquinol usa inc - carprofen (unii: ffl0d546ho) (carprofen - unii:ffl0d546ho) - carprofen 25 mg - vetprofen is indicated for the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. vetprofen should not be used in dogs exhibiting previous hypersensitivity to carprofen.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

edwards pharmaceutical, inc. - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv) - methenamine 81.6 mg

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

austin respiratory equipment,inc - oxygen (unii: s88tt14065) (oxygen - unii:s88tt14065) - oxygen 990 ml in 1 l

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

bpi labs llc - hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - hyoscyamine sulfate injection, usp is effective as adjunctive therapy in the treatment of peptic ulcer. in acute episodes, hyoscyamine sulfate injection, usp can be used to control gastric secretion, visceral spasm and hypermotility in spastic colitis, spastic bladder, cystitis, pylorospasm, and associated abdominal cramps. for use as adjunctive therapy in the treatment of irritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and functional gastrointestinal disorders. also as adjunctive therapy in the treatment of neurogenic bladder and neurogenic bowel disturbances (including the splenic flexure syndrome and neurogenic colon). parenterally administered hyoscyamine sulfate injection, usp is also effective in reducing gastrointestinal motility to facilitate diagnostic procedures such as endoscopy or hypotonic duodenography. hyoscyamine sulfate injection, usp may be used to reduce pain and hypersecretion in pancreatitis, in certain cases of partial heart block associated with vagal activity,

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

bpi labs llc - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - tetracaine hydrochloride is indicated for the production of spinal anesthesia for procedures requiring two to three hours. spinal anesthesia with tetracaine hydrochloride is contraindicated in patients with known hypersensitivity to tetracaine hydrochloride or to drugs of a similar chemical configuration (ester-type local anesthetics), or aminobenzoic acid or its derivatives; and in patients for whom spinal anesthesia as a technique is contraindicated. the decision as to whether or not spinal anesthesia should be used for an individual patient should be made by the physician after weighing the advantages with the risks and possible complications. contraindications to spinal anesthesia as a technique can be found in standard reference texts, and usually include generalized septicemia, infection at the site of injection, certain diseases of the cerebrospinal system, uncontrolled hypotension, etc.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

bpi labs llc - methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh) - drug-induced methemoglobinemia methylene blue can cause fetal harm when administered to a pregnant woman. an association exists between the use of methylene blue in amniocentesis and atresia of the ileum and jejunum, ileal occlusions, and other adverse effects in the neonate. (2, 3) methylene blue is contraindicated in women who are or may become pregnant. if this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. intraspinal and subcutaneous injections are contraindicated. methylene blue is contraindicated in patients with a known hypersensitivity to the drug.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

bpi labs llc - phenobarbital sodium (unii: sw9m9bb5k3) (phenobarbital - unii:yqe403bp4d) - - sedative. sedation is obtainable within an hour, and in adequate dosage, the duration of action is more than six hours. included in the more common conditions in which the sedative action of this class of drugs is desired are anxiety-tension states, hyperthyroidism, essential hypertension, nausea and vomiting of functional origin, motion sickness, acute labyrinthitis, pylorospasm in infants, chorea and cardiac failure. phenobarbital is also a useful adjunct in treatment of hemorrhage from the respiratory or gastrointestinal tract. phenobarbital controls anxiety, decreases muscular activity and lessens nervous excitability in hyperthyroid patients. however, thyrotoxic individuals occasionally react poorly to barbiturates. - hypnotic, for the short-term treatment of insomnia, since it appears to lose its effectiveness for sleep induction and sleep maintenance after 2 weeks (see clinical pharmacology ). -  preanesthetic. - long-term anticonvulsant, (phenobarbital, mephobarbital and metharbital) for the t

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

bpi labs llc - methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh) - drug-induced methemoglobinemia methylene blue can cause fetal harm when administered to a pregnant woman. an association exists between the use of methylene blue in amniocentesis and atresia of the ileum and jejunum, ileal occlusions, and other adverse effects in the neonate. (2, 3) methylene blue is contraindicated in women who are or may become pregnant. if this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. intraspinal and subcutaneous injections are contraindicated. methylene blue is contraindicated in patients with a known hypersensitivity to the drug.

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

bpi labs, llc - epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh) - epinephrine injection usp, 1 mg/ml is indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock. none risk summary prolonged experience with epinephrine use in pregnant women over several decades, based on published literature, does not identify a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. however, there are risks to the mother and fetus associated with epinephrine use during labor or delivery (see clinical considerations ). in animal reproduction studies, epinephrine administered by the subcutaneous route to pregnant rabbits, mice, and hamsters, during the period of organogenesis, resulted in adverse developmental effects (including gastroschisis, embryonic lethality, and delayed skeletal ossification) at doses approximately 2 times the maximum recommended daily intramuscular, subcutaneous, or intravenous dose (see data ). the estimated background risk of major birth defects and miscarriage

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

bpi labs llc - mycophenolate mofetil hydrochloride (unii: uxh81s8zvb) (mycophenolic acid - unii:hu9dx48n0t) - mycophenolate mofetil [mycophenolate mofetil (mmf)] is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see clinical studies (14.1)], heart [see clinical studies (14.2)] or liver transplants [see clinical studies (14.3)] , in combination with other immunosuppressants. allergic reactions to mycophenolate mofetil have been observed; therefore, mycophenolate mofetil is contraindicated in patients with a hypersensitivity to mycophenolate mofetil (mmf), mycophenolic acid (mpa) or any component of the drug product. mycophenolate mofetil for injection is contraindicated in patients who are allergic to polysorbate 80 (tween). pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to mycophenolate during pregnancy and those becoming pregnant within 6 weeks of discontinuing mycophenolate mofetil treatment. to report a pregnancy or obtain inform